TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹2,352 Cr | ₹1,847 Cr | ₹1,226 Cr | ₹1,526 Cr | ₹1,187 Cr |
What is the latest Profit Before Tax of TORRENT PHARMACEUTICALS ?
| Year | Profit Before Tax |
|---|---|
| Mar2025 | ₹2,352 Cr |
| Mar2024 | ₹1,847 Cr |
| Mar2023 | ₹1,226 Cr |
| Mar2022 | ₹1,526 Cr |
| Mar2021 | ₹1,187 Cr |
How is Profit Before Tax of TORRENT PHARMACEUTICALS Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,352 Cr | 27.34 | |
| Mar2024 | ₹1,847 Cr | 50.68 | |
| Mar2023 | ₹1,226 Cr | -19.68 | |
| Mar2022 | ₹1,526 Cr | 28.63 | |
| Mar2021 | ₹1,187 Cr | - | |
Compare Profit Before Tax of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹149,566.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
| MANKIND PHARMA | ₹94,121.6 Cr | 5.8% | 1.9% | -13.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 4.7% |
11.7% |
41.1% |
| SENSEX | -1.7% |
0.5% |
8.3% |
You may also like the below Video Courses